Phase 1 coagulopathy Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy

coagulopathySepsis

Bayer36 enrolled20 locationsNCT06854640

Recruiting

Phase 1

A Study of the Efficacy of Troxerutin in Preventing Thrombotic Events in COVID-19 Patients

COVID 19 Associated Coagulopathy

Westlake University80 enrolled1 locationNCT06355258